All companies
Visit website
Life Magnetics
OperatingLife Magnetics, Inc.
Founded 2013
An at-home medical testing platform funded by the National Science Foundation
Post-money valuation ⓘ
$5.6M
As of Jan 2024 · from LIFE MAGNETICS, INC. Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$751,987
Across 2 rounds since 2021
Latest share price
$64.95
LIFE MAGNETICS, INC. Preferred Stock 2 offering price
Financials
FY2018–FY2024 · from SEC filings · hover any figure for its source$19K
−$211K
2018
$14K
−$236K
2019
$33K
−$233K
2021
$44K
−$287K
2022
$2K
−$287K
2023
$3K
−$259K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$19,236
$14,235
$33,306
$44,083
$2,440
$3,195
Cost of goods sold
$18,998
$32,833
$112,006
$176,716
$77,346
$89,303
Gross margin
1%
-131%
-236%
-301%
-3070%
-2695%
Net income
-$210,806
-$236,462
-$232,759
-$287,133
-$286,924
-$258,709
Taxes paid
$6,639
$9,275
$0
$0
$0
$0
Balance sheet
Cash
$8,606
$12,710
$472,133
$193,716
$24,275
$180,037
Accounts receivable
$0
$11,596
$0
$0
$0
$1,275
Total assets
$99,018
$139,105
$574,193
$319,601
$124,854
$299,435
Short-term debt
$111,363
$138,694
$169,060
$174,244
$272,078
$8,648
Long-term debt
$3,839
$53,057
$20,000
$20,000
$20,000
$20,000
Total liabilities
$115,202
$191,751
$189,060
$194,244
$292,078
$28,648
Other
Headcount
—
2
—
3
—
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$3.7M
post-money
$5.6M
post-money
LIFE MAGNETICS, INC. Stock 1
LIFE MAGNETICS, INC. Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $91.9K / $618KInvestors 319Post-money $5.6M
Raised $660.1K / $1MInvestors 277Post-money $3.7M
Reg CF annual-report compliance
Delinquent
Filed 2 of 6 annual reports (FY2020–FY2025)
Missing: 2020, 2021, 2023, 2025
319 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001848586Share price $64.95
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.